Midwest Mezzanine Funds

Midwest Mezzanine Funds, established in 1992 and headquartered in Chicago, is a private equity firm specializing in mezzanine financing for middle market companies. The firm invests between $4 million and $15 million, focusing on mature companies, buyouts, acquisition finance, and recapitalizations. Its investment sectors include commercial products, industrial services, business services, and healthcare, excluding high technology, energy, and real estate. Midwest Mezzanine Funds can lead or participate in larger investments by co-investing with other mezzanine providers.

Michael Foster

Senior Managing Director

James Fox

Director

Paul Kreie

Senior Managing Director

Elliott Linsley

Director

Elizabeth E. Milz

Director of Finance

Peter Timotijevic

Associate

Jason Vandermyde

Senior Associate

Ana Winters

Senior Managing Director

1 past transactions

Denison Pharmaceuticals

Private Equity Round in 2013
Denison Pharmaceuticals is a prominent provider of contract manufacturing and packaging services tailored for the branded over-the-counter, prescription, cosmetic, and homeopathic markets. The company offers a diverse product portfolio that includes cough and cold medicines, skin care products, mouth rinses, topical analgesics, and nasal inhalers. Denison is committed to delivering comprehensive solutions that support clients throughout the entire product development process, from initial discovery and manufacturing to product launch and commercialization. Its focus on turn-key formulation, manufacturing, and packaging solutions ensures a seamless integration of services, catering to the specific needs of its clients in the pharmaceutical and cosmetic industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.